Immunohistochemical Analysis of Insular Carcinoma of the Thyroid Gland
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : Insular thyroid carcinoma (ITC) is a relatively infrequent thyroid carcinoma that has distinctive histologic features. ITC shows an aggressive clinical course and the predominant presence of an insular component, which has been reported to be an independent factor of a poor prognosis. We retrospectively examined clinical details of the nine ITC patients, which represented 9 years of experience with ITC, and investigated the expressions of variable neuroendocrine and other immunohistochemical markers associated with well-differentiated thyroid carcinomas. Methods : We adopted an immunohistochemical approach and studied the expressions of synaptophysin, chromogranin A, CD56, NSE, S-100, RET, PPAR , calcitonin, galectin-3, and thyroglobulin in formalin-fixed, paraffin embedded tissue array slides of the 9 ITC patients, and investigated clinical features. Seven cases of follicular carcinoma and 4 cases of medullary carcinoma were also included as controls. Results : ITCs were positive for synaptophysin (44%, 4/9), CD56 (11%, 1/9), NSE (89%, 8/9), S100 (67%, 6/9), calcitonin (22%, 2/9), galectin-3 (78%, 7/9), and thyroglobulin (100%, 9/9), but completely negative for chromogranin A, RET, and PPAR . Conclusion : ITCs express neuroendocrine markers in variable proportions and appear not to be associated with the oncoproteins of conventional thyroid carcinomas. Notably, its differential diagnosis from medullary carcinoma is required in cases showing focal calcitonin positivity.
참고문헌 (20)
- "Poorly differentiated thyroid carcinoma:introduction to the issue,its landmarks,and clinical impact", 15, pp.293~6 (2004)
- "A reinterpretation of Langhans’ ‘‘wuchernde Struma’’", 8(ma), pp.655~68
- "Papillary and follicular thyroid carcinomas with an insular component", 73, pp.416~23 (1994)
- "Insular component as a risk factor of thyroid carcinoma", 46, pp.939~46 (1996)
- "Long-term outcome of patients with insular carcinoma of the thyroid:the insular histotype is an independent predictor of poor prognosis", 95, pp.2076~85 (2002)
- "Thyroid carcinomas with distant metastases:a review of 111 cases with emphasis on the prognostic significance of an insular component", 26, pp.1007~15 (2002)
- "Clinical course of insular thyroid carcinoma", 10, pp.~11 (2004)
- "Neuroendocrine marker expression in thyroid epithelial tumors", 12, pp.291~9 (2001)
- "Immunohistochemical characterisation of a case of insular thyroid carcinoma", 33, pp.257~61 (2001)
- "A poorly differentiated thyroid carcinoma with neuroendocrine traits", 14, pp.163~4 (2004)
- "Medullary carcinoma of the thyroid gland and immunohistochemical features with review of the literature", fe(glio-preiser cm), pp.577~94
- "Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B", 74, pp.928~32 (1994)
- "Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid", 11, pp.551~6 (1987)
- "Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma", 6, pp.207~10 (1996)
- "Underexpression of peroxisome proliferator-activated receptor(PPAR)gamma in PAX8", PPA Rgamma-negative thyroid tumours, 2004, pp.91, 732~8
- "Expression of RET in follicular cell-derived tumors of the thyroid gland:Prevalence and implication of morphological type", 53, pp.146~53 (2003)
- "RET", PTC fusion gene rearrangements in Japanese thyroid carcinomas, 2005, pp.262, 368~73
- "RET", PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes, 1998, pp.4, 287~94[DOI]
- "Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET", PTC3 p53-, pp.2001, 20[DOI]
- "RET activation and clinicopathologic features in poorly differentiated thyroid tumors", 87, pp.370~9 (2002)